Search For "sars cov"
INSACOG to hold meeting today on genome sequencing and presence of differe
Updated : 3 years, 2 months ago IST
The Indian SARS-CoV-2 Consortium on Genomics (INSACOG) will hold a virtual meeting Friday evening on Genome sequencing which will focus on the genome sequencing results of international travellers who tested Covid-19 positive, sources told ANI.
Read More
Covid-19 booster increases durability of antibody response: Research
Updated : 3 years, 2 months ago IST
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l
Read More
Cystic fibrosis drug could help treat pneumonia: Research
Updated : 3 years, 2 months ago IST
Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome.
Read More
Covid-19 vaccine protects patients with blood cancer: Study
Updated : 3 years, 2 months ago IST
People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from COVID-19. Furthermore, several cancer treatments cause these individuals to develop little or no antibodies against SARS-CoV-2 after COVID-19 vaccination.
Read More
WHO chief again asks China to share requested data on COVID-19
Updated : 3 years, 2 months ago IST
Three years after its emergence in China's Wuhan, exactly how SARS-CoV-2 first emerged as a respiratory pathogen capable of sustained human-to-human transmission remains the subject of active debate.
Read More
Acids help against airborne viruses: Research
Updated : 3 years, 2 months ago IST
Viruses such as SARS-CoV-2, influenza virus and others travel from person to person essentially by hitchhiking on aerosols. These are finely dispersed particles containing liquid suspended in the air that an infected person expels when coughing, sneezing, or simply exhaling, and can be inhal
Read More
Research finds how antibody therapy impacts COVID vaccines
Updated : 3 years, 3 months ago IST
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
Read More
Research shows how a viral toxin may exacerbate severe COVID-19
Updated : 3 years, 3 months ago IST
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections. The study shows how a portion of the SARS-CoV-2 "spike" protein can damage cell barriers that line the inside of blood vessels within orga
Read More
Australian PM tests positive for COVID-19
Updated : 3 years, 3 months ago IST
This comes as WHO estimates that at least 90 per cent of the world's population now has some level of immunity to SARS-CoV-2, due to prior infection or vaccination.
Read More
Study sheds light on origins of Omicron virus
Updated : 3 years, 3 months ago IST
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed "Omicron" spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charite - Univers
Read More
New gadget identifies COVID-19 antibodies in five minutes
Updated : 3 years, 3 months ago IST
Rapid, low-cost, and accurate tests are still required for epidemiological surveillance and healthcare services to monitor and contain the spread of SARS-CoV-2. Brazilian researchers have contributed to this field's efforts by creating an electrochemical immunosensor that identifies antibodi
Read More
COVID-19 vaccination provides significant protection against reinfection:
Updated : 3 years, 3 months ago IST
According to a study, individuals who have already been infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from a vaccination as well, with 60% to 94% protection against reinfection, depending on the variation.
Read More